Company

Vitrolife AB

Headquarters: Gothenburg, Sweden

Employees: 1,171

CEO: Mr. Thomas Axelsson M.Sc.

OMX: VITR

Market Cap

kr23.03 Billion

SEK as of July 1, 2024

US$2.17 Billion

Market Cap History

Vitrolife AB market capitalization over time

Evolution of Vitrolife AB market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Vitrolife AB

Detailed Description

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It offers oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also provides EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.

Top 1-year algo backtest: +227.67%

$10,000 in September 2023 would now be $32,767 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Vitrolife AB has the following listings and related stock indices.


Stock: OMX: VITR wb_incandescent

Stock: FSX: VTFN wb_incandescent

Details

Headquarters:

Gustaf Werners gata 2

Gothenburg, 421 32

Sweden

Phone: 46 3 17 21 80 00

Fax: 46 3 17 21 80 99